Line 1,976: |
Line 1,976: |
| | | | | |
| |- | | |- |
− | | Langerhans Cell Histiocytosis||Disease|| | + | | Langerhans Cell Histiocytosis||Disease||Prashant Deshpande |
− | | | + | |10/26/2021 |
− | | | + | |1/26/2022 |
− | | | + | |Pending |
| | ||GC | | | ||GC |
| | | | | |
| | | | | |
| |- | | |- |
− | | Langerhans Cell Sarcoma||Disease|| | + | | Langerhans Cell Sarcoma||Disease||Prashant Deshpande |
− | | | + | |10/26/2021 |
− | | | + | |1/26/2022 |
− | | | + | |Pending |
| | ||GC | | | ||GC |
| | | | | |
Line 2,040: |
Line 2,040: |
| | | | | |
| |- | | |- |
− | |Erdheim-Chester Disease||Disease|| | + | |Erdheim-Chester Disease||Disease||Prashant Deshpande |
− | | | + | |10/26/2021 |
− | | | + | |1/26/2022 |
− | | | + | |Pending |
| | ||GC | | | ||GC |
| | | | | |